New York State Common Retirement Fund’s Standard BioTools LAB Stock Holding History

New York State Common Retirement Fund’s Portfolio LAB Stock Details LAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-79,000	Closed	-$72.6K	–	3263
2026 Q1	$72.6K	Hold	79,000	–	–	﹤0.01%	2673
2025 Q4	$101K	Hold	79,000	–	–	﹤0.01%	2595
2025 Q3	$103K	Hold	79,000	–	–	﹤0.01%	2610
2025 Q2	$94.8K	Hold	79,000	–	–	﹤0.01%	2719
2025 Q1	$85.3K	Hold	79,000	–	–	﹤0.01%	2585
2024 Q4	$138K	Hold	79,000	–	–	﹤0.01%	2460
2024 Q3	$152K	Sell	79,000 -43,200	-35%	-$84.6K	﹤0.01%	2417
2024 Q2	$216K	Buy	+122,200	New	+$299K	﹤0.01%	2389
2022 Q3	–	Sell	-546	Closed	-$1K	–	3374
2022 Q2	$1K	Sell	546 -51,819	-99%	-$128K	﹤0.01%	3370
2022 Q1	$188K	Buy	52,365 +46	+0.1%	+$159	﹤0.01%	2839
2021 Q4	$205K	Sell	52,319 -164	-0.3%	-$768	﹤0.01%	2867
2021 Q3	$346K	Buy	52,483 +182	+0.3%	+$1.2K	﹤0.01%	2666
2021 Q2	$322K	Buy	52,301 +601	+1%	+$3.21K	﹤0.01%	2811
2021 Q1	$234K	Hold	51,700	–	–	﹤0.01%	2777
2020 Q4	$310K	Sell	51,700 -13,500	-21%	-$88.7K	﹤0.01%	2574
2020 Q3	$484K	Sell	65,200 -17,019	-21%	-$117K	﹤0.01%	2229
2020 Q2	$330K	Sell	82,219 -7,781	-9%	-$27.1K	﹤0.01%	2428
2020 Q1	$229K	Buy	90,000 +450	+0.5%	+$1.48K	﹤0.01%	2403
2019 Q4	$312K	Sell	89,550 -23,600	-21%	-$83K	﹤0.01%	2527
2019 Q3	$524K	Sell	113,150 -7,500	-6%	-$59.1K	﹤0.01%	2302
2019 Q2	$1.49M	Buy	120,650 +46,800	+63%	+$596K	﹤0.01%	1801
2019 Q1	$981K	Buy	73,850 +16,550	+29%	+$174K	﹤0.01%	1970
2018 Q4	$494K	Buy	57,300 +37,500	+189%	+$292K	﹤0.01%	2288
2018 Q3	$148K	Hold	19,800	–	–	﹤0.01%	2953
2018 Q2	$118K	Sell	19,800 -19,100	-49%	-$109K	﹤0.01%	3057
2018 Q1	$227K	Buy	38,900 +12,600	+48%	+$82.7K	﹤0.01%	2690
2017 Q4	$155K	Hold	26,300	–	–	﹤0.01%	2864
2017 Q3	$133K	Hold	26,300	–	–	﹤0.01%	2937
2017 Q2	$106K	Sell	26,300 -16,329	-38%	-$77.4K	﹤0.01%	3080
2017 Q1	$243K	Buy	42,629 +4,154	+11%	+$26.3K	﹤0.01%	2696
2016 Q4	$280K	Hold	38,475	–	–	﹤0.01%	2645
2016 Q3	$308K	Hold	38,475	–	–	﹤0.01%	2569
2016 Q2	$347K	Buy	38,475 +12,175	+46%	+$114K	﹤0.01%	2448
2016 Q1	$212K	Hold	26,300	–	–	﹤0.01%	2648
2015 Q4	$284K	Hold	26,300	–	–	﹤0.01%	2585
2015 Q3	$213K	Sell	26,300 -3,655	-12%	-$57.5K	﹤0.01%	2752
2015 Q2	$725K	Buy	29,955 +5,620	+23%	+$177K	﹤0.01%	2357
2015 Q1	$1.02M	Buy	+24,335	New	+$962K	﹤0.01%	1859

Other funds holding LAB

PLC

Peapod Lane Capital Bedford Hills, New York $148M AUM 89.92% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Oppenheimer & Co New York $9.37B AUM 36.4% 1-Year Est. Return

MAM

Marquette Asset Management Minneapolis, Minnesota $779M AUM 23.4% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

EWA

EverSource Wealth Advisors Birmingham, Alabama $2.97B AUM 28.74% 1-Year Est. Return

PTP

Platform Technology Partners New York $611M AUM 25.5% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

MFG

Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return

New York State Common Retirement Fund's LAB Position: Q2 2026 in Review

New York State Common Retirement Fund sold out of Standard BioTools (LAB) in Q2 2026, closing a stake of 79,000 shares — an estimated $72.6K sold.

New York State Common Retirement Fund first reported a position in LAB in Q1 2015 and held it in 38 quarters. The position peaked at $1.49M in Q2 2019. 21 funds tracked by Wall St. Rank hold LAB as of Q2 2026.

New York State Common Retirement Fund reported no remaining Standard BioTools position as of Q2 2026 after selling out during the quarter.
New York State Common Retirement Fund sold 79,000 Standard BioTools shares in Q2 2026, an estimated $72.6K.
New York State Common Retirement Fund first reported a position in Standard BioTools in Q1 2015 and held it in 38 quarters.
New York State Common Retirement Fund's Standard BioTools position peaked at $1.49M in Q2 2019.
21 funds tracked by Wall St. Rank held Standard BioTools as of Q2 2026.

Based on New York State Common Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.